Methods of Inactivation of Highly Pathogenic Viruses for Molecular, Serology or Vaccine Development Purposes

Simon Elveborg1,2, Vanessa M Monteil3, Ali Mirazimi3,4

  • 1Department of Clinical Microbiology, Uppsala University Hospital, 751 85 Uppsala, Sweden.